GeneDx Holdings (WGS) Total Non-Current Liabilities (2020 - 2026)

GeneDx Holdings has disclosed Total Non-Current Liabilities across 7 years of filings, most recently posting $252.1 million for Q1 2026.

• In Q1 2026, Total Non-Current Liabilities rose 38.21% year-over-year to $252.1 million; the TTM figure through Mar 2026 stood at $252.1 million (up 38.21% YoY), while the FY2025 annual figure was $213.9 million, up 26.85% from the prior year.
• Total Non-Current Liabilities advanced to $252.1 million in Q1 2026, from $213.9 million in the prior quarter.
• Over the last five years, Total Non-Current Liabilities for WGS reached as high as $288.7 million in Q2 2022 and fell as low as $140.4 million in Q3 2023.
• The 5-year median for Total Non-Current Liabilities is $184.8 million (2022), against an average of $198.7 million.
• The widest YoY moves for Total Non-Current Liabilities: up 74.37% in 2022, down 54.55% in 2022.
• A 5-year view of Total Non-Current Liabilities shows it stood at $213.2 million in 2022, then decreased by 17.45% to $176.0 million in 2023, then declined by 4.2% to $168.6 million in 2024, then climbed by 26.85% to $213.9 million in 2025, then advanced by 17.87% to $252.1 million in 2026.
• According to Business Quant data, Total Non-Current Liabilities over the past three periods registered $252.1 million, $213.9 million, and $197.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.